The evolutionary trajectory of influenza and vaccine development

The effectiveness of the 2022-2023 season influenza vaccine ranges from 27% to 50%

This past influenza season marked a return to near pre-pandemic levels of influenza virus activity in EU/EEA countries. + read more

Clinical trials of new candidate for universal flu vaccine begin

Recruitment has begun for a Phase 1 trial of a new investigational universal influenza vaccine candidate targeting six strains of the virus. + read more

Experts recommend using enhanced immunogenicity vaccines to vaccinate against influenza

SEGG also believes it is important to recommend the vaccine to all people living with older people, as well as health professionals, social health professionals, gerontologists and all those who work with them. + read more

New influenza B vaccine protects against multiple influenza strains

A new generation vaccine candidate developed at Cleveland Clinic protects against multiple influenza B strains and lasts longer than currently used vaccines. + read more

WHO recognizes no vaccine can protect everyone against avian influenza

A total of 873 human H5N1 cases have been recorded in 21 countries over the past 20 years, with 458 resulting in deaths, according to the United Nations health agency. + read more

First case of human infection with H1N2 swine flu in the United States

Swine influenza A (H1N2) viruses are circulating among swine herds in many parts of the world. Human infection usually results from direct or indirect contact with pigs or contaminated environments. + read more